Status of Noninvasive Brain Stimulation in the Therapy of Alzheimer's Disease  

作　　者：Yi-Cong Lin Yu-Ping Wang 

机构地区：[1]Department of Neurology,Xuanwu Hospital,Capital Medical University,Beijing 100053,China [2]Beijing Key Laboratory of Neuromodulation,Beijing 100053,China [3]Center of Epilepsy,Beijing Institute for Brain Disorders,Capital Medical University,Beijing 100069,China

出　　处：《Chinese Medical Journal》2018年第24期2899-2903,共5页中华医学杂志（英文版）

摘　　要：Alzheimer's disease (AD),characterized by progressive memory impairment and dementia leading to severe deterioration of daily living,has been a public health crisis that currently lacks effective treatments.The reported prevalence of AD was 3.21% in people aged ≥65 years,More than 7 million people live with AD in China today and the number continues to increase.AD imposes a heavy financial burden on the society and it is becoming worse.The total socioeconomic costs of Chinese patients with AD was estimated to be US $167.74 billion in 2015 and is predicted to reach US $1.89 trillion by 2050.

关 键 词：Alzheimer's Disease NONINVASIVE BRAIN STIMULATION REPETITIVE Transeranial Magnetic STIMULATION TRANSCRANIAL Direct Current STIMULATION 

分 类 号：R[医药卫生]